Categories

Above the Fold

PHARMA/POLICY/POLITICS: FDA Official Quits Over Delay on Plan B, with UPDATE

The FDA official in charge of women’s health quits over the delay on Plan B‘s approval. Well it’s good to see that some of the staffers left at FDA have some spine, because it’s clear that, whatever the lies being told by the Administration, this is all about cow-towing to the loonies on the Christian right rather than the science of the situation.

There are a couple of telling shots in the story. Crawford swore up and down that this was his decision and that it was a science-based one.  Not so. 

Susan F. Wood, assistant FDA commissioner for women’s health and director of the Office of Women’s Health, said she was leaving her position after five years because Commissioner Lester M. Crawford’s announcement Friday amounted to unwarranted interference in agency decision-making. "I can no longer serve as staff when scientific and clinical evidence, fully evaluated and recommended for approval by the professional staff here, has been overruled," she wrote in an e-mail to her staff and FDA colleagues"I can no longer serve as staff when scientific and clinical evidence, fully evaluated and recommended for approval by the professional staff here, has been overruled," she wrote in an e-mail to her staff and FDA colleagues.

Of course there were strenuous denials from all concerned, but what was she told?

Wood also said other FDA officials who are typically involved in important matters were kept in the dark about the contraceptive, called Plan B, until Crawford announced his decision, which she believed was made at higher levels in the administration. Wood said that when she asked a colleague in the commissioner’s office when the decision would be made, the answer was, "We’re still awaiting a decision from above; it hasn’t come down yet."

So you could argue that this was not Crawford doing what he thought the loonies wanted him to do, but instead he was actually taking instructions from Leavitt or Rove or whomever.  On this issue  they can send a sop to their "social conservative" friends. After all it’s only a small pharma company they’re pissing off here, not a big one, Just as well Lipitor doesn’t impact birth control, eh?

Meanwhile, there’s just a delicious piece of doublespeak from Leavitt that really outdoes some of the stuff we’ve had to put with from Rumsfeld over the years:

Many supporters of the Plan B application — including Sens. Hillary Rodham Clinton (D-N.Y.) and Patty Murray (D-Wash.) — accused Crawford of making a political decision that ignored science and public health. The two senators were especially angry at Crawford’s ruling because they had lifted a hold on his pending nomination based on promises, relayed by HHS Secretary Mike Leavitt, that the Plan B issue would be resolved by Sept. 1.

Clinton and Murray have accused the administration of breaking its promise, but Leavitt has disagreed. "The commitment was they would act," he told Reuters on Monday. "Sometimes action isn’t always yes and no. Sometimes it requires additional thought.

So now when you’re asked by your wife, boss, teacher, whomever why you haven’t done something you were supposed to have done (you know, "taken action") you can tell them that you were thinking about it and that is exactly the same thing! Not only that — it’s now official policy in what passes for the circus we call a government.

UPDATE: Bob Steeves points me to this quote from the spokesman for Mike Enzi (a Senator with an "R" after his name), showing that he didn’t get the Talking Points on this one and looks a little pissed:

Sen. Michael B. Enzi (R-Wyo.), chairman of the Health, Education, Labor and Pensions Committee, is considering whether to hold hearings on the FDA’s handling of Plan B, said spokesman Craig Orfield. Enzi had expected "a firm decision" from the FDA, not further delays, Orfield said.

CONSUMERS: Trade up players, but maybe not enough of them

Once again there’s something very important in a WSJ/Harris poll which concentrates on the people that, when I was at Harris, were called the "Trade up players". These are the people with enough discretionary income to buy themselves a better class of service from their providers.  As I know many of you don’t have WSJ access, I’ve quoted most all of the results.

"Do you have health insurance? It could be from an employer, that you purchase yourself or from a government program like Medicare or Medicaid?"

Base: All Adults

Yes, have health insurance 87%
No, do not have health insurance 13

* * *

"Which one of these statements best describes you?"

Base: Adults with health insurance

Total
I only go to doctors that accept my health insurance 85%
I sometimes go to doctors who don’t accept my health insurance 15

* * *

"Whether or not you have done so in the past, how willing would you be to go to a doctor who doesn’t take your health insurance if he or she was highly recommended by a source that you trust?"

Chart1

"How willing would you be to pay the full cost of a doctor’s visit – rather than use your health insurance – if you . . .?"

Chart2

The important issue is that pretty uniformly, those with incomes over 50K, which is a little over average household income and around US median income, are willing to spend more money to get a better class of service. Obviously this means a couple of things

a) If you are marketing a health care service to wealthier Americans there is a willingness to pay for it. Of course that’s a well known fact to chiropractors, orthodontists, and cosmetic surgeons. But it might mean that other physicians and providers might start to think about providing better access and customer service, for a small fee (and I don’t mean insisting on $20,000 for concierge service). This is the Nordstroms approach, and one that health care providers should be thinking about emulating (and one that some are).

b) This willingness to pay is a minority effect — it’s a big minority and may be a majority in the case of referrals from someone the patient trusts.  But for most of these services more people are unwilling to pay extra, and of course large majorities of those with lower incomes, even those with health insurance, do not want to pay extra.

This tells me that continued bifurcation is likely to be the case when people seek health services that they have to pay out of pocket for, with roughly double the number who want to "trade up" skimping on "extras". Why does this matter?  Because in our brave new consumer world, cash may be an increasingly important way that patients pay for health care, especially for "minor" care out of their HSAs. So this correlates with much other data about user fees at the point of care–they tend to prevent lower income people from getting care (including often needed care).

Like it or not, we are slowly heading towards this future.  Unless, that is, you live in Rochester New York.

Meanwhile, (and this is a bit of a throwaway for Ron) the Kaiser Network Health Policy Report notes that the CBO is out with a study showing that "Uninsured workers are unlikely to purchase individual health insurance, regardless of whether they receive tax credits or other subsidies to help cover the cost of premiums, according to a report released on Friday by the Congressional Budget Office". Proving to my mind once again that high deductible health plans are not going to solve the uninsurance problem and that voluntary universal health care is a myth.

POLICY: Getting transparency in benefit costs, by Eric Novack

After his first post on how to get doctors to provide care to uninsured patients, surgeon, talkshow host and THCB podcast star Eric Novack is back with a second installment. And believe it or not I completely agree with him. Here’s Eric:
I want to introduce another component of an incremental approach to health care transformation.  Many of you will wonder why it even qualifies as a reform- it does not require legislation, does not redistribute, reclassify, or create.  But let’s summarize the last post and the very insightful and valuable comments:
  1. People who can demonstrate financial hardship can go to the doctor for care- at no charge to them. Doctors would get a tax credit for a predetermined value (e.g.. Medicare rate) of the services. Those who deliver care are given incentives to provide care to those who would otherwise feel inhibited to seek care. (see prev. post for more)

The next component:  Require that employee tax statements (W-2) include the amount that employers spend on health benefits.
Employers understand that employee compensation includes benefits.  As health care costs have soared, costs to employers have soared as well. For example, someone earning $30,000 a year in salary sees that number on the W-2. Employers, on their tax returns, list employee health benefits as a line item, because that amount is tax deductible (a topic worth several radio programs and many blogs in its own right…)
The employee is ‘blind’ to this exact cost. If the cost for an employee was listed, employers could demonstrate how much money the employee actually receives directly and indirectly. In the example, let’s make health benefits cost $5000. Now, the W-2 would have $35,000 as the total compensation, but $5000 would appear as a line item for ‘health benefits’, which would be subtracted for tax purposes.
One of the many fears about HSAs and CDHP is that costs will just be shifted — or, put another way — companies will add to their profits at the direct expense of employees. Since we know that HSA prices actually decreased (eHealthinsurance.com data), if companies are forced to be transparent to employees about healthcare costs, it will be much more difficult to ‘reduce compensation’, as opposed to using the savings to fund the HSA savings accounts.
A win for transparency, corporate oversight, and the promotion of CDHC.

BLOGS/PHARMA: John Mack on “ethical pharmaceutical marketing”

John Mack attributes one of my contributors words to me.  So first some remedial education.  When I say that this is The Industry Veteran’s views on XYZ, and here are The Veteran’s words, and I introduce that in an indented paragraph,  I mean that a guy calling himself The Industry Veteran wrote it and he is NOT me.  If an article appears here without such a paragraph you can assume that I wrote it. Sorry to be pedantic, but my desire to have differing view-points up here why this is called The Health Care Blog and not Matthew Holt shoots his mouth off about health care. It’s the same theory as the New York Times having  Paul Krugman and David Brooks both writing op-eds. I have enough opinions of my own without wishing to have other people’s attributed to me–even if I agree! And just to prove it I’ll have another article from Eric Novack up here very soon..

Meanwhile, what John has to say about the Veteran’s words is pretty interesting.  He notes that the tone set by pharma comes from the top, and I think that the Veteran would agree.

PHARMA: The Industry Veteran, on what the Vioxx verdict means

After too long an absence, The Industry Veteran is back to tell us what’s really the problem going on in big Pharma. It’s that short-term thinking has invaded its strategic marketing. I remeber being at a meeting in 1998 where then consultant and now big cheese at United Healthcare Bill Whitely warned pharma clients about becoming so keen on being consumer companies, and I think the Veteran would agree. Here’s the Veteran’s restrained tone (and I’m not kidding this time!)

A recent piece in a UK newsletter got me to thinking about some implications of last week’s Vioxx verdict. The newsletter contends that the core of Big Pharma’s problems began in the 90’s when marketing rather than research began to direct the industry’s course.  I would draw some other implications from the Vioxx scandal.  First, Merck’s malfeasance amply illustrates an argument I have made elsewhere on THCB: the Bush/Right Wing goal of an unregulated market for pharmaceuticals and most other aspects of healthcare remains delusional. Contrary to hosannas from market true believers, sick people either lack the time or the repose to make rational, profit-maximizing choices. Even if they possess such detachment, the asymmetry of information operating against them militates against rational, well informed choices. Moreover, consumers-patients have no idea of the bundled cascade of services or costs that follow from their choice of, say, a doctor or a hospital.   A second lesson of Vioxx is that many other parties must share some blame with Merck for furthering the promiscuous overuse of COX-2 inhibitors. Physicians and their professional societies now proclaim in high dudgeon that they were unduly influenced to overprescribe the COX’s by pharmaceutical sales reps, bountiful sample packs and deceitfully published articles. In fact their current wailing amounts to an admission that clinicians and their organizations failed to fulfill their professional responsibilities. For years the societies and the state licensing boards allowed physicians to complete their continuing medical education requirements by attending company-sponsored events. The manufacturers have been only too happy to relieve physicians of the need for footing the bill to keep up with advances in their  respective disciplines. Now the same physicians and their accomplices self righteously complain that they have been influenced by promotions. Do they honestly expect us to believe or empathize with their purported shock and outrage, expressed with all the sincerity and histrionic skill of WWF wrestlers?The third-party payers also contributed to Vioxx’s 150,000 hearts attacks and 50,000 deaths. These organizations failed to scrutinize the COX-2 studies and placed those drugs on their formularies, often without even the disincentive of higher co-payment requirements. Their coverage of the COX-2’s was not merely a result of deference to physicians’ preferences or consumers’ demands as much as it was an acceptance of bribery. Merck, Pfizer and the other manufacturers offer competing rebates on their products, thereby reducing pharmacy benefit costs for the payer organization. In such cases the HMOs’ formulary committees and their pharmacy benefit managers eagerly swallow the manfacturer’s claims of efficacy and safety.Contrary to Drug Researcher’s arraignment of marketing as the Vioxx culprit, I would claim that Merck and other Big Pharma companies practiced short-term gouging and exploitation that are the very opposite of smart marketing. Over the past 25 years the pharmaceutical industry has  enjoyed extraordinarily high returns on equity, assets and sales, often the highest of any global industry.  The American public has permitted the industry its enormous margins because of an implicit covenant. The pharmaceutical industry’s obligations under the agreement have included the following. (1) The industry must develop products that the public perceives as substantially improving the length and/or quality of life by advancing, each decade, the standard of care in one or another disease condition. Pharma came up short here. The number of new molecular entities that have appreciably advanced the standards of care within the last 10 years has declined considerably. The research paradigm of medicinal chemistry has already “picked the low hanging fruit” and the public correctly perceives that the industry uses a considerable portion of its research budget to develop patent-extending knockoffs.(2)  The industry must promote its products in a restrained, professional manner. This sotto voce element of the agreement went out with the trash in April of 1997 when industry lobbyists prevailed on Congress to permit direct-to-consumer advertising on a virtually unfettered basis. The restraint and scientific rigor befitting a research-driven industry conjoined to the medical establishment soon vanished. Big Pharma’s public face was no longer esoteric or dauntingly technical in a manner to command respect. Instead it began to advertise cholesterol medications with Dr. Seuss ads and southern football coaches. Pain relievers were promoted by ice skating champions and glamorous, middle-aged models doing tai chi in the park. The public can endure such fantasy and hyperbole when it comes to soft drinks or automobiles that sell good times and sex over the intrinsic features of those products. When Pharma stooped to the same lowest-common-denominator, however, its exalted image went out with the empty bottles of Pepsi.(3)  The industry must not price its products beyond the reach of its core customers: the elderly.  Pharma’s lobbying group, the PhRMA, and its lackeys in the media (e.g., the Philadelphia Inquirer) still adamantly contend that Americans must pay double and triple the prices paid by Europeans and others to fund further research. For a while that argument maintained traction but the public now knows that Pharma spends considerably more on SG&A than on research while the total compensation of top executives runs from $30 million to $50 million a year. Of course the concurrent erosion of the wider, employment-based health care system has also helped take the veil off Pharma’s unconscionable pricing. As tiered co-payments became the norm, 28-year old mothers who purchase oral antibiotics for their children must now pay $20 and $30 for the same products that used to cost them only $5 or $10.In short, Pharma has cooked its own golden goose by failing to meet expected standards for product development, by deceptively huckstering its promotions, and by using spurious rationalizations to overcharge its customers. That, ladies and gentlemen, constitutes the opposite of elementary marketing principles. Perhaps I might then differ with Drug Researcher by saying that Pharma has switched from a research-driven industry to one that is driven by bad and unethical marketing.

PHARMA: Vioxx–can we usher in a grown-up era?

Every week I write a brief editorial for my FierceHealthcare newsletter (and if you haven’t signed up yet, why not? It’s free and daily). Today’s was of course about last week’s Vioxx jury verdict. I may be an optimist but here goes:

This week’s news was dominated by last Friday’s verdict in the Vioxx case that was either a decisive blow against the evils of capitalism or the end of Western civilization as we know it, depending on your point of view. The Vioxx case is perhaps a sentinel event. It could be what’s needed to spur big Pharma, the FDA, the medical profession and the public into a new compact. In this new era everything that is known about a drug, pre-and post-market approval, would be tracked, reported publicly and analyzed, and the collusion between pharma and the FDA would need to end. The risks and rewards of taking these drugs would be clearly understood. Pharma would have to change their marketing dramatically (much more so than the minor restrictions on DTC) and accept lower profits and the public would have to accept that there are risks as well as magic in pill bottle, but that for some patients they’re worth taking. Physicians and pharmacists would have to spend much more time educating the public and themselves.

This grown up view about pharmaceuticals may not fit our needs for black and white outcomes, but it is in line with the "consumer" health care system we are moving towards. And if we don’t get there, the more likely future is restrictions on drug development and supply that will overall hurt patients, an over-cautious FDA, and grumpy big Pharma continuing to play dodgeball.

INTERNATIONAL/PHYSICIANS: Canadian doctors going home means the US sucks, n’est-ce pas?

This one I find hilarious and gives me great deal of personal satisfaction. The pro-American health care system, "it’s the finest on earth crowd" goes on and on about how terrible the Canadian system is and how all the doctors are leaving. In fact it was that sentiment especially from the wonderful, but confused, Sydney Smith over at Medpundit that inspired my "Oh Canada" tome.  (Actually I re-read "Oh Canada" the other day and it’s a pretty damn good piece of analysis if I say so myself).

Syd was basically saying that all the doctors were leaving cos they hated the clinical restrictions of the single payer system and wanted to move to the glorious homeland of free-choice medical practice and CABGs for 97 year olds. I showed pretty conclusively using actual real life data that a) very few doctors were leaving Canada for the US, and that b) if they were leaving it wasn’t that surprising as they get paid about twice as much by sneaking below the 49th parallel.

Well now we have more actual statistics and real data that shows that more Canadian doctors are heading back to Canada than are leaving — and this was in 2004 when hockey was on strike so there was no real reason to go to Canada! The numbers are:

Canada has seen more doctors returning than leaving for the first time in 30 years, a report by the Canadian Institute for Health Information (CIHI) shows. The report, released Wednesday, says that between 2000 and 2004,the number of physicians leaving Canada declined by 38 percent. In 2004, 317 physicians returned to Canada and 262 left. That was a drop from 2000, when 420 doctors left the country and a significant decrease from the peak of 771 physicians who moved abroad in 1994.

I’m looking forward to the barrage of articles from the know-it all alleged "free-market" crowd who get spoon-fed rubbish by Frasier, PRI, Manhattan et al offering their apologies to the Canadians and admitting that their system is better than the one down here.  After all the alleged rush of Canadian doctors to the US was absolute proof in their mind that the reverse was true.

I’m waiting, I’m waiting….

POLICY: Gladwell on Moral Hazard, with UPDATE

Go read Malcolm Gladwell on Moral Hazard in the New Yorker.

Gladwell basically thinks that there’s some moral imperative on the part of the political right to promote user fees at the point of care and that it’s uniquely American.  The bit about it being uniquely American is not quite right, in that I first heard the term from a Japanese health ministry official explaining why they had (very low) user fees in Japan, and in the UK there have been user fees for Rx forever. But there’s no question that we have more of them here. The wise Canadians Evans and Barer list user fees at the point of care as one of their Zombies — bad health care ideas that won’t die. Their interpretation of the RAND study is succinct and correct:

Contrary to the rhetoric, the RAND evidence demonstrated clearly that patients could not discriminate between necessary and unnecessary services. User fees were as likely to deter important health-preserving or enhancing care, as “frivolous” abuse. Moreover, the deterrent effects of user charges bear more heavily upon those with lower incomes, as this group is more sensitive to increases in price. In fact, low-income persons reduced use of care that was judged by researchers to be highly effective more frequently than did their higher-income counterparts.

They go on to note that user fees at the point of care are not designed to reduce overall health care costs — after all here in the US we lead the league in both categories. Instead they’re designed by providers to try to spike their incomes. Remember that as it’ll be important later….

Gladwell of course acknowledges all that and realizes that the "actuarial" model of health insurance that is being promoted by the HSA and its backers (Hi Ron!) is designed to basically to allow those with the greatest ability to get out of paying for those with the greatest need. Of course social insurance is based on the idea of transferring resources from those who have them to those who need them. In fact there’s nothing wrong with the idea at all and if you look at Americans when they’re surveyed about it, by and large they agree.  Those of you who read my recent article on Why Hillarycare Failed may remember that Harris got the following answers on the subject in 2003:

By 75% to 21% (including a 66% to 30% majority of Republicans), most people agree that "people who are unemployed or poor should be able to get the same amount and quality of medical services as people who have good jobs and are paying substantial taxes".

By 69% to 27% (including a 63% to 32% majority of Republicans), most people disagree that "it’s fair that people who pay more in taxes (or in health insurance premiums) should be able to get better medical care than those who pay little or nothing."

But despite the fact that apparently Americans prefer the concept of social insurance, Gladwell doesn’t really come up with an explanation for why the HSA legislation has done so well, other than the primacy of ideas. He makes a lot of the influence of Mark Pauly. Pauly is a complete idiot respected health economist at Wharton, who earnestly believes both that the individual market works well for 80% of the people forced to be in it and is therefore OK, and that the reason we spend so much money on health care in America is a result of the fact that the rest of our economy is so dang efficient. (Both in serious studies published in Health Affairs — I shit you not). And his article on moral hazard is supposed to be the most influential ever published in the health policy literature, and that’s why the right has bought into it.

Of course those of us in the reality-based as opposed to faith/idea-based world think that there may be a couple of other reasons other than the strenght of ideas as to why the HSA is so popular amongst the right, and why they want to spread it to all programs including Medicare.

The first is purely political. The two big government programs of Medicare and Social Security are very, very popular and identified correctly with Democrats. There is a strong element (e.g. Grover Norquist and the WSJ Editorial pages) in today’s Republican party which wants to destroy those programs, or at least eliminate the middle classes’ dependency on them, so that their recipients are less likely to identify with Democrats and less likely to elect them to power. Electing Democrats to power of course interferes with those Republicans’ view of the real mission of government, which apparently is to plunder the treasury and hand out massive rewards to favored interests in the oil, defense, mining, pharmaceutical, etc, etc, industries, and ensure that the ultra-rich don’t have to pay much or any tax. These Republicans see the vast army of baby boomers heading towards Social Security and Medicare as a huge threat to their political future, and rightly so. Putting all Social Security and Medicare into private accounts, and as a side issue removing the social insurance aspect of those programs, is a political solution to breaking what they believe to be (what’s left of) a political machine-like dependency of the middle-class seniors on the Democrats. And I’m not convinced they’re wrong about that.

The other reason is of course much more basic and is to do purely with money. What creating tax-free HSAs does is to enable insurance companies to sell highly underwritten and incredibly profitable high-deductible insurance policies. HSAs and MSAs were developed by small insurance companies to incentivize the sale of high-deductible plans which cream-skim way healthy people from the big managed care companies. Golden Rule, run by loony Rooney, almost invented this category on its own, and massively funded Gingrich and the VRWC all the way through the 1990s. See this Mother Jones article on Rooney and Golden Rule in 1996 and one from 2004 on their success in getting HSAs through in the Medicare legislation.

Incidentally the AMA and America’s doctors also started supporting HSAs because they thought it would enable them to get out from under their PPO and managed care contracts and charge their patients directly (and get more money, as Evans and Barer suggested earlier). Unfortunately for the doctors, now that Wellpoint, United et al have taken over the game, the high-deductible plans of now and the future will have the same negotiated contracts, the same confusion over who owes what, and will just change their office managers from chasing health insurers for big lump sum payments to chasing patients for tiny ones instead. Tough break, guys.

Meanwhile, back to the insurance side. The big insurance companies went down the managed care path in the 1990s because both they thought that they would get the continued support of the employers to beat up on the providers (which they didn’t when the economy got better) and because they thought that Hillarycare would put everyone into big pools. Big pools are of course the world where managed care plans come from and they destroy the advantage of the smaller insurers — their ability to underwrite on an individual patient basis. As it turned out the big guys were wrong (slightly in part because of what the HIAA and Golden Rule’s money did to the Clinton Plan), and anyone who knows the story of the Aetna turnaround can see that it was by adopting much tougher underwriting that Aetna became the profit machine it now is. Imitation is not though the most sincere form of flattery, not when United Healthcare showed its admiration by buying Golden Rule for $900 odd million in 2003 and making loony Rooney even richer and even more able to spread his money around wacko-political operations.

Gladwell, however, fails to explain why putting HSAs into a social insurance program like Medicare is the beginning of the end for the program, and if you read the THCB comments section you’ll see plenty of information from Ron about how HSAs are all sweetness, light, and crumbly candy bars.  So — hopefully once and for all — I’ll explain why they are not. This will involve numbers, so pay attention.

Let’s assume that Medicare has 100 people in it. Let’s also assume that it costs $5,000 per person. (I’m using the $5,000 number because it’s practically identical to the numbers and in the same ratio that Ron Grenier used when he tried to sell me a policy yesterday before he found that he can’t in California, so we know they’re correct for high-deductible plans). So in the HSA dreamtime world each of our 100 seniors gets $2500 in an HSA account, and then the remaining $2,500 goes into a pool totalling $250,000 which will pay for the care of anyone who’s individual expenditures exceed $2,500. Now you need to know something about population health costs. They roughly follow the 80/20 rule, in that 80% of the money gets spent on 20% of the population. So in our 100 person Medicare, 80 people need $100,000 worth of care, while 20 need $400,000 worth of care.

Here’s the maths problem that no one on the HSA-backing side will admit to. The 80 people spending $1,250 each are fine and happy and have a further $1,250 left in their accounts. The 20 sicker people have spent their full $2,500 each and in total need a further $350,000 from the pool to pay for their care. But there’s only $250,000 in the pool because the rest of it is in the HSA accounts of the healthy 80. So now we have to make up the extra $100,000. So we can increase taxes, and spend $600,000 to provide $500,000 worth of care — not too likely to be popular (although something like that happened in Medicare managed care in the 1990s). Or we can pay providers less money for caring for the sick. Or we can look to the sickies to come up with the extra. Or we can not provide them with that care.

Any which way you look at this, we are essentially starting down the track of destroying the social insurance nature of Medicare, and the willingness of providers to take part in it. We’ve basically already done it with every other form of health insurance with the exception of the unionized, large employer market, and so in the commercial market the HSA/high-deductible plan looks similar but better than what’s already available. Unless of course you are sick, and then you run into those nasty underwriting trends because, guess what, insuring sick people breaks a pool financially — even if it’s a private-sector high-deductible underwriting pool. Which is why Golden Rule, Aetna and the rest don’t do it much any more.

And although Gladwell doesn’t seem to quite get the politics, the incentives or the mechanism, he does understand the overall impact.

The issue about what to do with the health-care system is sometimes presented as a technical argument about the merits of one kind of coverage over another or as an ideological argument about socialized versus private medicine. It is, instead, about a few very simple questions. Do you think that this kind of redistribution of risk is a good idea? Do you think that people whose genes predispose them to depression or cancer, or whose poverty complicates asthma or diabetes, or who get hit by a drunk driver, or who have to keep their mouths closed because their teeth are rotting ought to bear a greater share of the costs of their health care than those of us who are lucky enough to escape such misfortunes? In the rest of the industrialized world, it is assumed that the more equally and widely the burdens of illness are shared, the better off the population as a whole is likely to be. The reason the United States has forty-five million people without coverage is that its health-care policy is in the hands of people who disagree, and who regard health insurance not as the solution but as the problem.

I agree with the sentiment, but I though prefer the language of this great American hero who described essentially the same problem in 1945.

No, but you . . . you . . . you’re thinking of this place all wrong. As if I had the money back in a safe. The money’s not here. Your money’s in Joe’s house . . .(to one of the men). . . right next to yours. And in the Kennedy house, and Mrs. Macklin’s house, and a hundred others. Why, you’re lending them the money to build, and then, they’re going to pay it back to you as best they can. Now what are you going to do? Foreclose on them?

Apparently we’re all leaving Bedford Falls and going to live in PottersVille.

assetto corsa mods